These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7537376)

  • 1. Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.
    Thomas JW; Baum CM; Hood WF; Klein B; Monahan JB; Paik K; Staten N; Abrams M; McKearn JP
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3779-83. PubMed ID: 7537376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist.
    Abegg AL; Vickery LE; Bremer ME; Donnelly AM; Doshi PD; Evans ML; Thurman TL; Braford SR; Caparon MH; Bauer SC; Giri JG; Welply JK; McKearn JP; Smith WG
    Leukemia; 2002 Mar; 16(3):316-26. PubMed ID: 11896534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin.
    McWherter CA; Feng Y; Zurfluh LL; Klein BK; Baganoff MP; Polazzi JO; Hood WF; Paik K; Abegg AL; Grabbe ES; Shieh JJ; Donnelly AM; McKearn JP
    Biochemistry; 1999 Apr; 38(14):4564-71. PubMed ID: 10194378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells.
    Yonemura Y; Ku H; Hirayama F; Souza LM; Ogawa M
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4040-4. PubMed ID: 8633013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interleukin-3: a preclinical study].
    Valent P; Geissler K; Bettelheim P
    Wien Klin Wochenschr; 1989 Oct; 101(19):652-63. PubMed ID: 2482586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF): two cytokines increasing histamine synthesis by hematopoietic cells.
    Dy M; Schneider E
    Eur Cytokine Netw; 1991; 2(3):153-72. PubMed ID: 1716491
    [No Abstract]   [Full Text] [Related]  

  • 7. New role for histamine in interleukin-3-induced proliferation of hematopoietic stem cells.
    Schneider E; Piquet-Pellorce C; Dy M
    J Cell Physiol; 1990 May; 143(2):337-43. PubMed ID: 1970573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.
    Emerson SG; Yang YC; Clark SC; Long MW
    J Clin Invest; 1988 Oct; 82(4):1282-7. PubMed ID: 3049674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates.
    Gillio AP; Gasparetto C; Laver J; Abboud M; Bonilla MA; Garnick MB; O'Reilly RJ
    J Clin Invest; 1990 May; 85(5):1560-5. PubMed ID: 2332507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of early hematopoietic precursors in human cord blood.
    Abboud M; Xu F; LaVia M; Laver J
    Exp Hematol; 1992 Oct; 20(9):1043-7. PubMed ID: 1281782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in proliferation of the hematopoietic cell line TF-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human IL-3.
    Schweiger A; Stern D; Lohman IC; Baldini M; Martinez FD; Halonen M
    J Allergy Clin Immunol; 2001 Mar; 107(3):505-10. PubMed ID: 11240952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of murine bone marrow natural suppressor activity in the fraction of hematopoietic progenitors with interleukin 3 receptor-associated antigen.
    Sugiura K; Ikehara S; Inaba M; Haraguchi S; Ogata H; Sardiña EE; Sugawara M; Ohta Y; Good RA
    Exp Hematol; 1992 Feb; 20(2):256-63. PubMed ID: 1531958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF.
    van Gils FC; Budel LM; Burger H; van Leen RW; Löwenberg B; Wagemaker G
    Exp Hematol; 1994 Mar; 22(3):248-55. PubMed ID: 7509288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding site.
    Graham GJ; Wilkinson PC; Nibbs RJ; Lowe S; Kolset SO; Parker A; Freshney MG; Tsang ML; Pragnell IB
    EMBO J; 1996 Dec; 15(23):6506-15. PubMed ID: 8978677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L; Heimfeld S; Broxmeyer HE
    Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture.
    Shull RM; Suggs SV; Langley KE; Okino KH; Jacobsen FW; Martin FH
    Exp Hematol; 1992 Oct; 20(9):1118-24. PubMed ID: 1281786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.